W.R. Berkley Corp’s GP-Act III Acquisition Corp GPAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.18M Buy
846,823
+534,533
+171% +$5.75M 0.49% 40
2025
Q4
$3.34M Buy
312,290
+14,298
+5% +$152K 0.16% 105
2025
Q3
$3.16M Hold
297,992
0.18% 101
2025
Q2
$3.14M Hold
297,992
0.16% 113
2025
Q1
$3.07M Hold
297,992
0.18% 85
2024
Q4
$3.02M Hold
297,992
0.12% 73
2024
Q3
$3M Buy
+297,992
New +$2.99M 0.17% 71

Other funds holding GPAT

W.R. Berkley Corp's GPAT Position: Q1 2026 in Review

W.R. Berkley Corp increased its GP-Act III Acquisition Corp (GPAT) stake by 171% in Q1 2026, buying an estimated $5.75M and bringing the position to 846,823 shares worth $9.18M. The position accounts for 0.49% of the portfolio, ranked #40.

W.R. Berkley Corp first reported a position in GPAT in Q3 2024 and has held it in 7 quarters since. 51 funds tracked by Wall St. Rank hold GPAT as of Q1 2026.

  • W.R. Berkley Corp held 846,823 shares of GP-Act III Acquisition Corp worth $9.18M as of Q1 2026.
  • W.R. Berkley Corp bought 534,533 GP-Act III Acquisition Corp shares in Q1 2026, an estimated $5.75M.
  • GP-Act III Acquisition Corp made up 0.49% of W.R. Berkley Corp's portfolio in Q1 2026, its #40 holding.
  • W.R. Berkley Corp first reported a position in GP-Act III Acquisition Corp in Q3 2024 and has held it in 7 quarters since.
  • 51 funds tracked by Wall St. Rank held GP-Act III Acquisition Corp as of Q1 2026.

Based on W.R. Berkley Corp's 13F filing for Q1 2026, filed 15 May 2026.